Focal Muscle Vibration and tDCS on Motor Recovery in Stroke
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Mar 24, 2025
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of two therapies, Focal Muscle Vibration (FV) and transcranial Direct Current Stimulation (tDCS), on helping people recover motor function after having a stroke. Researchers believe that using these two treatments together might be more effective than using them separately, especially for individuals who experience muscle stiffness or spasticity as a result of their stroke. The goal is to see if this combination can lead to better movement and overall function for stroke survivors.
To participate in the trial, individuals must be at least 14 years old and have experienced a stroke that has left them with some chronic muscle stiffness. They should have a certain level of movement ability, as measured by a specific test, and should not have any other neurological disorders or orthopedic issues that could affect their recovery. Participants will receive the combined treatment and will be closely monitored to evaluate how well it helps with their motor recovery. If you're interested in this study, it could be a great opportunity to contribute to research that aims to improve recovery for stroke patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Chronic stroke
- • Spasticity \> 1 at Modified Ashworth Scale.
- • FMA score more than 36
- Exclusion Criteria:
- • Metallic implant including shunt, intracranial pacemaker, surgical clip etc.
- • Any neurological disorder other than stroke
- • Any Orthopedic impairment that limit the motor recovery
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rawalpindi, Punjab, Pakistan
Patients applied
Trial Officials
Mirza Obaid Baig, MSPT
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported